Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist

PURPOSE: Previous studies have shown that several components of the metabolic syndrome, such as hypertension, obesity or imbalanced lipid and carbohydrate homeostasis, are associated with the sympathetic nervous system overactivity. Therefore, the inhibition of the adrenergic nervous system seems to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotańska, Magdalena, Kulig, Katarzyna, Marcinkowska, Monika, Bednarski, Marek, Malawska, Katarzyna, Zaręba, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902538/
https://www.ncbi.nlm.nih.gov/pubmed/29110282
http://dx.doi.org/10.1007/s40618-017-0779-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902538/
https://www.ncbi.nlm.nih.gov/pubmed/29110282
http://dx.doi.org/10.1007/s40618-017-0779-7

Ejemplares similares